HK1059884A1 - Selective dopamine d4 receptor agonists for treating sexual dysfunction - Google Patents

Selective dopamine d4 receptor agonists for treating sexual dysfunction

Info

Publication number
HK1059884A1
HK1059884A1 HK04101320A HK04101320A HK1059884A1 HK 1059884 A1 HK1059884 A1 HK 1059884A1 HK 04101320 A HK04101320 A HK 04101320A HK 04101320 A HK04101320 A HK 04101320A HK 1059884 A1 HK1059884 A1 HK 1059884A1
Authority
HK
Hong Kong
Prior art keywords
receptor agonists
sexual dysfunction
treating sexual
selective dopamine
dopamine
Prior art date
Application number
HK04101320A
Other languages
English (en)
Inventor
Jorge D Brioni
Teodozyj Kolasa
Gin C Hsieh
Diane L Donnelly-Roberts
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27109879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1059884(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/985,974 external-priority patent/US20020103105A1/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HK1059884A1 publication Critical patent/HK1059884A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK04101320A 2000-11-22 2004-02-24 Selective dopamine d4 receptor agonists for treating sexual dysfunction HK1059884A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71831100A 2000-11-22 2000-11-22
US09/985,974 US20020103105A1 (en) 2000-11-22 2001-11-07 Use of selective dopamine D4 receptor agonists for treating sexual dysfunction
PCT/US2001/043139 WO2002041894A2 (en) 2000-11-22 2001-11-21 Selective dopamine d4 receptor agonists for treating sexual dysfunction

Publications (1)

Publication Number Publication Date
HK1059884A1 true HK1059884A1 (en) 2004-07-23

Family

ID=27109879

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04101320A HK1059884A1 (en) 2000-11-22 2004-02-24 Selective dopamine d4 receptor agonists for treating sexual dysfunction

Country Status (25)

Country Link
EP (1) EP1345608B1 (xx)
JP (1) JP2004534725A (xx)
KR (1) KR20030051857A (xx)
CN (1) CN1531434A (xx)
AR (1) AR035600A1 (xx)
AT (1) ATE358483T1 (xx)
AU (2) AU2689502A (xx)
BG (1) BG107810A (xx)
BR (1) BR0110450A (xx)
CA (1) CA2429383A1 (xx)
CZ (1) CZ20031458A3 (xx)
DE (1) DE60127712T2 (xx)
ES (1) ES2284727T3 (xx)
HK (1) HK1059884A1 (xx)
HU (1) HUP0402358A3 (xx)
IL (1) IL155094A0 (xx)
MX (1) MXPA03004547A (xx)
NO (1) NO20032304L (xx)
NZ (1) NZ525086A (xx)
PE (1) PE20020557A1 (xx)
PL (1) PL365890A1 (xx)
SK (1) SK7242003A3 (xx)
TW (1) TWI293254B (xx)
UY (1) UY27031A1 (xx)
WO (1) WO2002041894A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
CA2486564A1 (en) * 2002-05-23 2003-12-04 Abbott Laboratories Acetamides and benzamides that are useful in treating sexual dysfunction
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
EP2037927B1 (en) 2006-06-30 2010-01-27 Boehringer Ingelheim International GmbH Flibanserin for the treatment of urinary incontinence and related diseases
JP5793828B2 (ja) 2006-08-14 2015-10-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング フリバンセリンの製剤及びその製造方法
EP2056797A2 (en) 2006-08-25 2009-05-13 Boehringer Ingelheim International GmbH Controlled release system and method for manufacturing the same
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
EP2697206B1 (en) * 2011-04-10 2019-04-03 Atir Holding S.A. Heterocyclic compounds and uses thereof in the treatment of sexual disorders
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT775118E (pt) * 1994-08-05 2003-10-31 Pfizer Derivados de benzimidazole com actividade dopaminergica
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
EP0982030A3 (en) * 1998-08-17 2000-05-10 Pfizer Products Inc. 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
US6291471B1 (en) * 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males

Also Published As

Publication number Publication date
ATE358483T1 (de) 2007-04-15
BG107810A (bg) 2004-02-27
KR20030051857A (ko) 2003-06-25
EP1345608A2 (en) 2003-09-24
MXPA03004547A (es) 2004-03-26
AR035600A1 (es) 2004-06-16
CA2429383A1 (en) 2002-05-30
CN1531434A (zh) 2004-09-22
UY27031A1 (es) 2002-07-31
ES2284727T3 (es) 2007-11-16
AU2689502A (en) 2002-06-03
DE60127712D1 (de) 2007-05-16
NO20032304D0 (no) 2003-05-21
PE20020557A1 (es) 2002-06-25
IL155094A0 (en) 2003-10-31
NZ525086A (en) 2006-07-28
DE60127712T2 (de) 2007-12-27
JP2004534725A (ja) 2004-11-18
EP1345608B1 (en) 2007-04-04
BR0110450A (pt) 2005-02-09
HUP0402358A2 (hu) 2005-03-29
PL365890A1 (en) 2005-01-10
SK7242003A3 (en) 2004-01-08
NO20032304L (no) 2003-07-15
CZ20031458A3 (cs) 2004-02-18
WO2002041894A2 (en) 2002-05-30
WO2002041894A3 (en) 2002-10-17
AU2002226895B2 (en) 2006-10-12
HUP0402358A3 (en) 2009-08-28
TWI293254B (en) 2008-02-11

Similar Documents

Publication Publication Date Title
IL155368A0 (en) Ep4 receptor selective agonists in the treatment of osteoporosis
ZA200007694B (en) EP4 receptor selective agonists in the treatment of osteoporosis.
HUP0201184A2 (en) Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
AU2003295686A8 (en) Tenaculum-like device for intravaginal operations
HK1104308A1 (en) Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
HUP0202687A3 (en) Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
HK1059884A1 (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction
HUP0202253A3 (en) Selective iglur5 receptor antagonists for the treatment of migraine
EP1121939A3 (en) Treatment of osteoporosis with EP2/EP4 receptor selective agonists
HK1081850A1 (en) Morpholine derivatives for use as dopamine agonists in the treatment of i.a. sexual dysfunction
PL370842A1 (en) Selective dopamin d3 receptor agonists for the treatment of sexual dysfunction
IL154215A0 (en) Medicine for fighting against sexual dysfunction
GB0026947D0 (en) Selective glucocorticoid receptor agonists
TW435085U (en) Improved device for tranquilizing pigs
TW472525U (en) Device for removing testicles from rooster
PL344493A1 (en) Aiming device for mortars
GB0000432D0 (en) Mounting apparatus for pipes
PL338162A1 (en) Apparatus for obtaining activated water
MY155220A (en) Selective dopamine d4 receptor agonists for treating sexual dysfunction
SI1307192T1 (sl) Kandesartan za zdravljenje migrene
ZA200005850B (en) β2- Adrenergic receptor agonists.
GB0115161D0 (en) Selective glucocorticoid receptor agonists
GB0006759D0 (en) Apparatus for fishing
PL110623U1 (en) Pipe cutting-off apparatus

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101121